Next-Generation ADCs for GPCR-Expressing Tumors: Unlocking New Therapeutic Opportunities
Time: 4:30 pm
day: Conference Day One
Details:
- GPCRs as Emerging Targets: Understanding the role of GPCRs in oncogenic signaling and tumor progression
- Tumor-Specific GPCR Targeting: Designing ADCs with enhanced selectivity for tumorassociated GPCR isoforms
- Combination Strategies: Exploring synergistic effects of SKM-104 ADC with checkpoint inhibitors, chemotherapy, or radiotherapy
